State Street SPDR S&P 600 Small Cap Growth ETF (SLYG) is a publicly traded the market company. As of May 21, 2026, SLYG trades at $107.12 with a market cap of $0 and a P/E ratio of 0.00. SLYG moved +1.99% today. Year to date, SLYG is +0.00%; over the trailing twelve months it is flat. Its 52-week range spans $0.00 to $0.00. Rallies surfaces SLYG's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Hims & Hers Settles Patent Dispute with Novo Nordisk; Shares Jump 48.7%: Hims & Hers ended its patent dispute with Novo Nordisk to distribute semaglutide via its telehealth platform, lifting shares 48.7% in premarket. Q4 revenue of $617.8M slightly missed the $619.2M consensus while EPS jumped to $0.08 from $0.03, and Q1 revenue guidance of $600M–$625M trails the $653.1M forecast.
| Metric | Value |
|---|---|
| Price | $107.12 |
| Market Cap | $0 |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $0.00 |
| 52-Week Low | $0.00 |
| Volume | 107.52K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
SLYG analyst coverage data. Average price target: $0.00.